Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Income from Non-Controlling Interests (2018 - 2021)

Amphastar Pharmaceuticals (AMPH) has 4 years of Income from Non-Controlling Interests data on record, last reported at -$855000.0 in Q2 2021.

  • For Q2 2021, Income from Non-Controlling Interests fell 169.12% year-over-year to -$855000.0; the TTM value through Jun 2021 reached -$1.7 million, down 944.66%, while the annual FY2021 figure was -$1.2 million, 287.25% down from the prior year.
  • Income from Non-Controlling Interests reached -$855000.0 in Q2 2021 per AMPH's latest filing, down from $1.1 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $6.6 million in Q4 2019 and bottomed at -$8.1 million in Q3 2019.
  • Average Income from Non-Controlling Interests over 4 years is $143818.2, with a median of $481000.0 recorded in 2020.
  • Peak YoY movement for Income from Non-Controlling Interests: plummeted 948.38% in 2019, then skyrocketed 155.19% in 2021.
  • A 4-year view of Income from Non-Controlling Interests shows it stood at -$773000.0 in 2018, then surged by 960.16% to $6.6 million in 2019, then tumbled by 92.77% to $481000.0 in 2020, then plummeted by 277.75% to -$855000.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Income from Non-Controlling Interests were -$855000.0 in Q2 2021, $1.1 million in Q1 2021, and $481000.0 in Q4 2020.